Team:Exeter/Achievements

From 2012.igem.org

(Difference between revisions)
m (typo)
Line 28: Line 28:
   <font color="#1b1b1d" size="2" face="Verdana">
   <font color="#1b1b1d" size="2" face="Verdana">
     <ul>
     <ul>
-
     <li style="list-style-image: url(https://static.igem.org/mediawiki/2012/9/99/Exe2012Tick.jpg);">Successfully cloned and submitted 32 biobricks into the registry</li>
+
     <li style="list-style-image: url(https://static.igem.org/mediawiki/2012/9/99/Exe2012Tick.jpg);">Successfully cloned and submitted 14 biobricks into the registry</li>
     <li style="list-style-image: url(https://static.igem.org/mediawiki/2012/9/99/Exe2012Tick.jpg);">Obtained <i>wbbC</i> gene from BL21 genome</li>
     <li style="list-style-image: url(https://static.igem.org/mediawiki/2012/9/99/Exe2012Tick.jpg);">Obtained <i>wbbC</i> gene from BL21 genome</li>
     <li style="list-style-image: url(https://static.igem.org/mediawiki/2012/9/99/Exe2012Tick.jpg);">Created GlycoBase; a database containing a list of >100 glycosyltransferase enzymes  
     <li style="list-style-image: url(https://static.igem.org/mediawiki/2012/9/99/Exe2012Tick.jpg);">Created GlycoBase; a database containing a list of >100 glycosyltransferase enzymes  

Revision as of 09:52, 25 September 2012

Protocol 6

Achievements and Failures
  • Successfully cloned and submitted 14 biobricks into the registry
  • Obtained wbbC gene from BL21 genome
  • Created GlycoBase; a database containing a list of >100 glycosyltransferase enzymes from E.coli strains to demonstrate the vast linkages we could achieve only with E.coli enzymes
  • Created GlycoWeb, an interface for an online user to access Glycobase with a polysaccharide in mind and the database searches and finds the enzymes you’d use to make it.
  • Created GlycoApp; an application for a handheld device to access the Glycobase from wherever the consumer is when they realise they need a polysaccharide ordering!
  • Considered human practice approaches and discussed with several experts the human practice considerations, hosted a human practice panel and discussed with the wider community at Café Scientifique.
  • Discussed our project with various businesses including Shell, Ginsters etc. and we received letters of support from DSTL, ISCA Biochemical Ltd, Avon.
  • Demonstrated that….. Successfully expressed this polysaccharide….. (to be cont….)
  • Made promoter-RBS-gene-terminator constructs for each gene


  • A correct mass analysis of the product is essential, but cannot alone confirm the correct product. The possibility that an incorrect product has been made through incorrect synthesis or post-synthetic regiospecific or enantiospecific rearrangement by chemical or enzymatic means must be examined and ruled out before the method can be considered reliable.
  • Synthesis of a previously well characterised small polysaccharide, which can be physically and also biochemically characterised, to show that the product will act in biological systems as expected. Once a fully characterised polysaccharide is produced, we would be in a much stronger position to offer novel products and to start to address the exciting possibilities of our method.
  • Only managed to obtain 7 of 9 fragments for Gibson assembly through PCR.
  • Didn’t manage to construct operons through BioBrick assembly.